Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Medpace stock
Learn how to easily invest in Medpace stock.
Medpace Holdings Inc is a diagnostics & research business based in the US. Medpace shares (MEDP) are listed on the NASDAQ and all prices are listed in US Dollars. Medpace employs 4,800 staff and has a trailing 12-month revenue of around $1.3 billion.
How to buy shares in Medpace
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MEDP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Medpace stock price (NASDAQ: MEDP)Use our graph to track the performance of MEDP stocks over time.
Medpace shares at a glance
|Latest market close||$156.14|
|52-week range||$126.95 - $231.00|
|50-day moving average||$161.45|
|200-day moving average||$161.46|
|Wall St. target price||$145.33|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$5.38|
Buy Medpace shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Medpace stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Medpace price performance over time
|1 week (2022-09-23)||7.40%|
|1 month (2022-08-29)||0.70%|
|3 months (2022-06-30)||4.32%|
|6 months (2022-03-29)||-5.78%|
|1 year (2021-09-30)||-17.51%|
|2 years (2020-09-30)||39.72%|
|3 years (2019-09-30)||85.79%|
|5 years (2017-09-29)||389.47%|
Is Medpace stock undervalued or overvalued?
Valuing Medpace stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medpace's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medpace's P/E ratio
Medpace's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, Medpace shares trade at around 27x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
Medpace's PEG ratio
Medpace's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.97. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medpace's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Medpace's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $254.5 million.
The EBITDA is a measure of a Medpace's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.3 billion|
|Operating margin TTM||18.12%|
|Gross profit TTM||$701.3 million|
|Return on assets TTM||10.46%|
|Return on equity TTM||36.87%|
|Market capitalisation||$4.5 billion|
TTM: trailing 12 months
Medpace share dividends
We're not expecting Medpace to pay a dividend over the next 12 months.
Medpace share price volatility
Over the last 12 months, Medpace's shares have ranged in value from as little as $126.945 up to $231. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Medpace's is 1.4674. This would suggest that Medpace's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio. .
Medpace in the news
Medpace Holdings, Inc. to Report Third Quarter 2022 Financial Results on October 24, 2022
Insiders who bought Medpace Holdings, Inc. (NASDAQ:MEDP) last year must be regretting not buying more as market cap hits US$4.8b
Medpace (MEDP) Stock Sinks As Market Gains: What You Should Know
Frequently asked questionsWhat percentage of Medpace is owned by insiders or institutions?
Currently 23.489% of Medpace shares are held by insiders and 87.839% by institutions. How many people work for Medpace?
Latest data suggests 4,800 work at Medpace. When does the fiscal year end for Medpace?
Medpace's fiscal year ends in December. Where is Medpace based?
Medpace's address is: 5375 Medpace Way, Cincinnati, OH, United States, 45227 What is Medpace's ISIN number?
Medpace's international securities identification number is: US58506Q1094 What is Medpace's CUSIP number?
Medpace's Committee on Uniform Securities Identification Procedures number is: 58506Q109
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert